• English
    • français
  • Help
  •  | 
  • Contact
  •  | 
  • About
  •  | 
  • Login
  • HAL portal
  •  | 
  • Pages Pro
  • EN
  •  / 
  • FR
View Item 
  •   LillOA Home
  • Liste des unités
  • METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
  • View Item
  •   LillOA Home
  • Liste des unités
  • METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Routine drug resistance testing in proviral ...
  • BibTeX
  • CSV
  • Excel
  • RIS

Document type :
Article dans une revue scientifique: Article original
DOI :
10.1002/jmv.25474
PMID :
30927451
Permalink :
http://hdl.handle.net/20.500.12210/17053
Title :
Routine drug resistance testing in proviral hiv-1 dna: prevalence of stop codons and hypermutation, and associated factors
Author(s) :
Alidjinou, Enagnon Kazali [Auteur]
Deldalle, J. [Auteur]
Robineau, Olivier [Auteur] refId
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Hallaert, C. [Auteur]
Meybeck, Agnes [Auteur]
Huleux, Thomas [Auteur]
Ajana, Faiza [Auteur]
Hober, Didier [Auteur] refId
Pathogenèse virale du diabète de type 1 - ULR 3610 [Laboratoire de Virologie]
Bocket, Laurence [Auteur]
Pathogenèse virale du diabète de type 1 - ULR 3610 [Laboratoire de Virologie]
Journal title :
Journal of medical virology
Abbreviated title :
J. Med. Virol.
Publication date :
2019-03-30
ISSN :
1096-9071
English keyword(s) :
hypermutation
drug resistance
HIV-1 DNA
stop codons
sequencing
mutations
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
We investigated the presence of stop codons (SC) and/or hypermutation (HM) in HIV-1 DNA sequences generated for routine drug resistance testing in proviral HIV-1 DNA, and sought for associated factors. At least one SC was ...
Show more >
We investigated the presence of stop codons (SC) and/or hypermutation (HM) in HIV-1 DNA sequences generated for routine drug resistance testing in proviral HIV-1 DNA, and sought for associated factors. At least one SC was identified in 6.2% of HIV-1 DNA sequences, among which 54.8% were hypermutated. The defective virus group (SC w/o HM) was similar to the non-SC group regarding the characteristics of HIV-1 infection, and before drug exposure. In addition, the HIV-1 DNA levels were not different between both groups. Sequences with SC/HM displayed a higher proportion of RAMs. The impact of the SC/HM associated RAMs on clinical responses requires further investigation.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
CHU Lille
Université de Lille
Collections :
  • METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
  • Pathogenèse virale du diabète de type 1 - ULR 3610
Submission date :
2019-12-09T16:54:41Z
Université de Lille

Mentions légales
Université de Lille © 2017